Developmental and behavioral pediatricians' attitudes toward screening for fragile X.

Acharya et al. (2013) asked developmental-behavioral pediatricians how they feel about newborn screening for fragile-X syndrome. The team mailed a short survey to DBPs across the United States. Doctors answered yes-or-no questions and rated their own knowledge of the condition.

Most doctors liked the idea of testing every baby for fragile-X. At the same time, most admitted they did not fully understand the range of problems the test can uncover. Support was high, but confidence in their own genetics know-how was low.

Finucane et al. (2013) ran a nearly identical survey the same year. They asked autism clinicians instead of DBPs and got the same result: people want FXS data but lack FXS facts. The two papers act as conceptual replications, showing the knowledge gap is wide across professions.

Scott et al. (2026) picked up the story where the 2013 survey left off. They followed families whose newborns actually screened positive. Only half of those babies were in early-intervention programs by age one. The later study extends the DBP survey by revealing that good intentions do not automatically turn into speedy services.

Dougherty et al. (1994) took the opposite path. They screened only children who already looked high-risk and still found FXS at solid rates. That earlier work reminds us that targeted testing can work, yet today’s doctors lean toward universal screens.

If universal fragile-X screening becomes routine, BCBAs will see more infants with a positive result on your caseload. Expect referrals before delays show up, and be ready to explain to families why therapy can help even when the baby looks typical. Use the DBP survey as a cue to build your own FXS knowledge: know the motor and language red flags, link families to genetics counselors, and track Part C paperwork early so the 50% enrollment gap found by Scott et al. (2026) does not happen on your watch.